Under fire for Truvada U.S. pricing at House hearing, Gilead chief O’Day touts R&D costs, asserts governments patents are void

May 17, 2019 |
Women Who Miscarry Could Be Criminally Investigated Under Georgia’s New Abortion Law
What’s behind PEPFAR’s funding cut threats?
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...